Wilson Sonsini Goodrich & Rosati advised Terray on the transaction. Terray Therapeutics (Terray), a biotechnology company, announced raising $120 million in Series B funding round. The...
Terray Therapeutics’ $120 Million Series B Funding
IBM’s $6.4 Million Acquisition of HashiCorp
Paul Weiss Rifkind Wharton & Garrison is advising IBM on the transaction, and Wilson Sonsini Goodrich & Rosati is advising HashiCorp. IBM (NYSE: IBM) and HashiCorp Inc....
Rambus’ $50 Million Accelerated Share Repurchase Program
Wilson Sonsini Goodrich & Rosati represented Rambus in the transaction. Rambus Inc. (NASDAQ: RMBS) announced that it initiated an accelerated share repurchase program with Royal Bank of Canada...
Denali Therapeutics’ $500 Million Private Placement Financing
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics Inc. on the transaction. Denali Therapeutics (Nasdaq: DNLI) announced that it entered into a securities purchase agreement with...
Neurona Therapeutics’ $120 Million Financing
Wilson Sonsini Goodrich & Rosati advised Neurona Therapeutics on the transaction. Neurona Therapeutics announced it closed a $120 million financing co-led by Viking Global Investors and Cormorant...
Alector’s $75 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati represented Alector in the offering, and Davis Polk & Wardwell represented the sole book-running manager and underwriter, Cantor Fitzgerald & Co....
Nextdata’s $12 Million Seed Financing Round
Wilson Sonsini Goodrich & Rosati advised Nextdata on the transaction. Nextdata announced it has raised a total of $12 million in seed investment, led by Greycroft and Acrew Capital, with participation...
ReCode Therapeutics’ $120 Million Series B Financing
Wilson Sonsini Goodrich & Rosati represented ReCode Therapeutics in the transaction. ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of...
HashiCorp’s Initial Public Offering
Wilson Sonsini Goodrich & Rosati advised HashiCorp on the deal. Latham & Watkins represented the underwriters. HashiCorp®, a leader in multi-cloud infrastructure automation software, announced the pricing...
Blend’s IPO
Wilson Sonsini Goodrich & Rosati advised Blend on the deal while Goodwin Procter represented the underwriters. Blend Labs, Inc. announced the pricing of its initial public...
Lifelink Systems’ $9.75 Million Series A Funding
Wilson Sonsini Goodrich & Rosati advised Lifelink Systems on the deal. Oakland, California-based Lifelink Systems announced that it has completed its Series A funding round, raising...